Published in Int J Mol Sci on August 29, 2012
Organ-on-a-chip platforms for studying drug delivery systems. J Control Release (2014) 1.06
Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther (2013) 0.87
Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis. J Mol Genet Med (2013) 0.78
Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil. J Thorac Dis (2014) 0.75
Conducting polymer-based multilayer films for instructive biomaterial coatings. Future Sci OA (2015) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A (2003) 12.17
Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev (2003) 7.08
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A (1997) 6.92
Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett (2005) 6.02
Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol (2009) 3.16
Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev (2000) 2.85
Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem (1984) 2.82
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Regulation of mucociliary clearance in health and disease. Eur Respir J (1999) 2.43
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer (2010) 2.35
Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett (2009) 1.97
Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol (2003) 1.88
Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res (1997) 1.87
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis (2012) 1.84
Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol (1976) 1.83
Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J Clin Invest (1996) 1.81
The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther (1999) 1.81
Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols. Am Rev Respir Dis (1980) 1.75
In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem (2008) 1.64
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum Gene Ther (1997) 1.59
IL-12 deaths: explanation and a puzzle. Science (1995) 1.58
Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes. J Control Release (2010) 1.56
Adenovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J Immunol (1994) 1.53
Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res (2005) 1.46
Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis (1977) 1.43
Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. Cancer Gene Ther (2012) 1.41
Treatment of pulmonary neuroendocrine tumours: state of the art and future developments. Cancer Treat Rev (2012) 1.37
Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther (2001) 1.36
Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther (2003) 1.31
Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol (2003) 1.27
Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine (2012) 1.27
Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci (2005) 1.26
Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther (2007) 1.22
Lactoferrin structure and functions. Adv Exp Med Biol (2008) 1.22
Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release (2005) 1.19
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell Immunol (2001) 1.19
Targeted drug delivery and penetration into solid tumors. Med Res Rev (2011) 1.19
Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release (2002) 1.19
Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine (2012) 1.18
Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J Virol (1999) 1.17
Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine (2011) 1.16
Interrelationships of the volume and time components of individual breaths in resting man. J Physiol (1975) 1.16
Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther (1998) 1.16
Detection of nonpolar molecules by means of carrier scattering in random networks of carbon nanotubes: toward diagnosis of diseases via breath samples. Nano Lett (2009) 1.15
Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis (1993) 1.13
Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther (2006) 1.09
Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Ther (2000) 1.09
Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs? J Pharm Sci (2010) 1.08
Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther (2001) 1.07
Modelling the lymphatic system: challenges and opportunities. J R Soc Interface (2012) 1.06
Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol (1998) 1.06
'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol Cell Biol (2008) 1.05
Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol (1999) 1.05
The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials (2009) 1.05
Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer. Nucleic Acids Res (2004) 1.02
Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype. Lung Cancer (2012) 1.02
In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med (2000) 1.01
Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res (2004) 1.01
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res (2007) 1.01
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. Int J Nanomedicine (2012) 1.01
Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Crit Rev Biomed Eng (2012) 1.00
Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques. Mol Ther (2002) 1.00
Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J Immunol (1998) 1.00
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm (2005) 1.00
Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol Ther (2008) 0.99
Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther (2002) 0.98
Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. J Gene Med (2005) 0.98
Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials (2004) 0.97
Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res (2007) 0.97
Lymphatics in lung disease. Ann N Y Acad Sci (2008) 0.97
Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res (1999) 0.97
Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J (2005) 0.96
Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med (2008) 0.96
Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Mol Carcinog (2012) 0.96
Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. Invest New Drugs (2011) 0.95
Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res (2004) 0.95
Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. Mol Ther (2000) 0.94
WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth. Cancer Gene Ther (2009) 0.93
Gene therapy for pulmonary diseases. Chest (2001) 0.93
Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process. J Pharm Sci (2003) 0.93
Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Eur J Pharm Biopharm (2009) 0.92
Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy. J Drug Target (2003) 0.92
Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. Clin Cancer Res (2003) 0.92
Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther (2001) 0.91
Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer (2006) 0.91
Advances in noninvasive pulmonary gene therapy. Curr Drug Deliv (2006) 0.91
In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy. Int J Nanomedicine (2012) 0.91
A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomedicine (2012) 0.91
Distribution of lymphatic stomata on the pleural surface of the thoracic cavity and the surface topography of the pleural mesothelium in the golden hamster. Anat Rec (1997) 0.91
Differential expression and estrogen response of lactoferrin gene in the female reproductive tract of mouse, rat, and hamster. Biol Reprod (2002) 0.90
Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content. Int J Nanomedicine (2012) 0.90
Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer. Clin Cancer Res (2010) 0.90
Self-assembled mPEG-PCL-g-PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro. Int J Nanomedicine (2012) 0.89
Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int J Nanomedicine (2012) 0.89
Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res (2012) 0.89
Chitosan-interferon-β gene complex powder for inhalation treatment of lung metastasis in mice. J Control Release (2010) 0.88
Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int (2006) 0.88
[New chemotherapeutic method for the treatment of tracheal and bronchial cancers--nebulization chemotherapy]. Gan No Rinsho (1983) 0.88
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J (2010) 3.68
Functional involvement of Tudor and dPRMT5 in the piRNA processing pathway in Drosophila germlines. EMBO J (2009) 1.94
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J (2010) 1.83
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J (2011) 1.63
Catamenial pneumothorax: a rare entity? Report of 5 cases and review of the literature. J Thorac Dis (2012) 1.63
Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J (2012) 1.59
Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol (2013) 1.49
Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis (2013) 1.49
Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis. Drug Des Devel Ther (2013) 1.37
Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. J Cancer (2013) 1.31
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis. Int J Cancer (2009) 1.29
Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review. Ther Clin Risk Manag (2012) 1.18
Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine (2012) 1.18
Application of flexible bronchoscopy in inhalation lung injury. Diagn Pathol (2013) 1.15
Endometriosis of the lung: report of a case and literature review. Eur J Med Res (2013) 1.15
Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Des Devel Ther (2013) 1.14
Determination of twelve heparin- and heparan sulfate-derived disaccharides as 2-aminoacridone derivatives by capillary zone electrophoresis using ultraviolet and laser-induced fluorescence detection. Electrophoresis (2002) 1.13
Intensive care unit and lung cancer: when should we intubate? J Thorac Dis (2013) 1.10
Lymphangioleiomyomatosis: current and future. J Thorac Dis (2013) 1.10
Effete-mediated degradation of Cyclin A is essential for the maintenance of germline stem cells in Drosophila. Development (2009) 1.10
Malignant pleural effusion and algorithm management. J Thorac Dis (2013) 1.09
MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation. Am J Physiol Renal Physiol (2008) 1.08
Biogenesis pathways of piRNAs loaded onto AGO3 in the Drosophila testis. RNA (2010) 1.08
Otefin, a nuclear membrane protein, determines the fate of germline stem cells in Drosophila via interaction with Smad complexes. Dev Cell (2008) 1.06
Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J Biol Chem (2006) 1.06
Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression. Adv Pharmacol (2006) 1.06
Therapeutic procedure in small cell lung cancer. J Thorac Dis (2013) 1.06
Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. J Biol Chem (2011) 1.05
Lumican, a small leucine-rich proteoglycan. IUBMB Life (2008) 1.05
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer. Onco Targets Ther (2013) 1.04
The biology of small leucine-rich proteoglycans in bone pathophysiology. J Biol Chem (2012) 1.04
Lung ossification: an orphan disease. J Thorac Dis (2013) 1.03
Bronchoscopic intratumoral chemotherapy of lung cancer. Lung Cancer (2008) 1.01
Video assisted thoracoscopic plication of the left hemidiaphragm in symptomatic eventration in adulthood. J Thorac Dis (2012) 1.01
Interleukin-8 and interleukin-17 for cancer. Cancer Invest (2014) 1.00
Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells. Mol Oncol (2008) 0.99
Resection of a giant bilateral retrovascular intrathoracic goiter causing severe upper airway obstruction, 2 years after subtotal thyroidectomy: a case report and review of the literature. J Thorac Dis (2012) 0.99
Derivatization of carbohydrates for chromatographic, electrophoretic and mass spectrometric structure analysis. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.98
Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer. Lung Cancer (2005) 0.98
Silencing receptor EphA2 induces apoptosis and attenuates tumor growth in malignant mesothelioma. Am J Cancer Res (2011) 0.98
Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation. Int J Cancer (2007) 0.98
Williams-Campbell syndrome: a case report. Int J Gen Med (2012) 0.97
Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC). J Thorac Dis (2013) 0.96
Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res (2007) 0.96
The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. In Vivo (2008) 0.96
Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism. Int J Biochem Cell Biol (2008) 0.95
Interleukin-6 cytokine: a multifunctional glycoprotein for cancer. Immunome Res (2013) 0.95
Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity. Int J Biochem Cell Biol (2011) 0.95
Abdominal wall endometrioma mimicking an incarcerated hernia: a case report. Int J Gen Med (2012) 0.94
Caveolin-1 directly interacts with UT-A1 urea transporter: the role of caveolae/lipid rafts in UT-A1 regulation at the cell membrane. Am J Physiol Renal Physiol (2009) 0.94
Glomus tumor in the lung parenchyma. J Thorac Dis (2012) 0.94
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study. Drug Des Devel Ther (2013) 0.94
Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. BMC Cancer (2011) 0.94
Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells. FEBS J (2007) 0.93
Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells. PLoS One (2013) 0.92
Lung cancer surgery: an up to date. J Thorac Dis (2013) 0.92
Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. FEBS J (2014) 0.92
Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med (2012) 0.92
Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring? Eur Respir J (2012) 0.91
Malignant pleural mesothelioma: current and future perspectives. J Thorac Dis (2013) 0.91
Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology. Future Oncol (2013) 0.91
An extracellular Staphylococcus epidermidis polysaccharide: relation to Polysaccharide Intercellular Adhesin and its implication in phagocytosis. BMC Microbiol (2012) 0.90
Management of complex benign post-tracheostomy tracheal stenosis with bronchoscopic insertion of silicon tracheal stents, in patients with failed or contraindicated surgical reconstruction of trachea. J Thorac Dis (2012) 0.90
Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases. Planta Med (2010) 0.90
Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Int J Nanomedicine (2013) 0.90
Advanced bronchoscopic techniques in diagnosis and staging of lung cancer. J Thorac Dis (2013) 0.90
Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells. Mol Cancer Res (2008) 0.90
Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small cell lung cancer with polypoid growth causing erroneous impression of advanced disease. Lung Cancer (2006) 0.90
A case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomy. J Multidiscip Healthc (2012) 0.89
Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol (2005) 0.89
Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts. Mol Cancer Res (2008) 0.89
Glycosaminoglycans as key molecules in atherosclerosis: the role of versican and hyaluronan. Curr Med Chem (2010) 0.89
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies. Drug Des Devel Ther (2013) 0.88
Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases. FEBS J (2013) 0.88
Metabolism and biochemical/physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation. Biomed Chromatogr (2006) 0.88
Targeted lung cancer therapy using ephrinA1-loaded albumin microspheres. J Pharm Pharmacol (2011) 0.88
Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther (2013) 0.87
Proteomic comparison of 3D and 2D glioma models reveals increased HLA-E expression in 3D models is associated with resistance to NK cell-mediated cytotoxicity. J Proteome Res (2014) 0.87